Literature DB >> 17100633

On scaffolds and hopping in medicinal chemistry.

Nathan Brown1, Edgar Jacoby.   

Abstract

The molecular scaffold is an oft-cited concept in medicinal chemistry suggesting that the definition of what makes a scaffold is rigorous and objective. However, this is far from the case with the definition of a scaffold being highly dependent on the particular viewpoint of a given scientist. It follows, therefore, that the definition of scaffold hopping and, more importantly, the detection of what constitutes a scaffold hop, is also ill-defined and highly subjective. Essentially, it is agreed that scaffolds should be substantially different from each other, although significantly similar to each other, to constitute a hop. In the latter, the scaffolds must permit a similar geometric arrangement of functional groups to permit the mode of action. However, this leaves the paradox of how to describe both scaffold similarity and dissimilarity simultaneously. In this paper, the current statuses of scaffolds and scaffold hopping are reviewed based on published examples of scaffold hopping from the literature. An investigation of the degree to which it is possible to formulate a more rigorous definition of scaffolds and hopping in the context of molecular topologies is considered. These techniques are adapted from chemoinformatics to be applied in the design of new medicinal compounds.

Mesh:

Substances:

Year:  2006        PMID: 17100633     DOI: 10.2174/138955706778742768

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  21 in total

1.  Comparison of structure fingerprint and molecular interaction field based methods in explaining biological similarity of small molecules in cell-based screens.

Authors:  Pekka Tiikkainen; Antti Poso; Olli Kallioniemi
Journal:  J Comput Aided Mol Des       Date:  2008-12-03       Impact factor: 3.686

2.  ScafBank: a public comprehensive Scaffold database to support molecular hopping.

Authors:  Bi-Bo Yan; Meng-Zhu Xue; Bing Xiong; Ke Liu; Ding-Yu Hu; Jing-Kang Shen
Journal:  Acta Pharmacol Sin       Date:  2009-01-19       Impact factor: 6.150

3.  Indirect similarity based methods for effective scaffold-hopping in chemical compounds.

Authors:  Nikil Wale; Ian A Watson; George Karypis
Journal:  J Chem Inf Model       Date:  2008-04-11       Impact factor: 4.956

4.  Analysis and use of fragment-occurrence data in similarity-based virtual screening.

Authors:  Shereena M Arif; John D Holliday; Peter Willett
Journal:  J Comput Aided Mol Des       Date:  2009-06-18       Impact factor: 3.686

5.  Structural and Activity Profile Relationships Between Drug Scaffolds.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2015-02-20       Impact factor: 4.009

6.  Systematic assessment of scaffold distances in ChEMBL: prioritization of compound data sets for scaffold hopping analysis in virtual screening.

Authors:  Ruifang Li; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2012-09-13       Impact factor: 3.686

Review 7.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

8.  Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort.

Authors:  Ying-Duo Gao; Yuan Hu; Alejandro Crespo; Deping Wang; Kira A Armacost; James I Fells; Xavier Fradera; Hongwu Wang; Huijun Wang; Brad Sherborne; Andreas Verras; Zhengwei Peng
Journal:  J Comput Aided Mol Des       Date:  2017-10-06       Impact factor: 3.686

9.  Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics.

Authors:  Mustapha Haddach; Michael K Schwaebe; Jerome Michaux; Johnny Nagasawa; Sean E O'Brien; Jeffrey P Whitten; Fabrice Pierre; Pauline Kerdoncuff; Levan Darjania; Ryan Stansfield; Denis Drygin; Kenna Anderes; Chris Proffitt; Josh Bliesath; Adam Siddiqui-Jain; May Omori; Nanni Huser; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2012-05-08       Impact factor: 4.345

10.  Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.

Authors:  Garrett C Moraski; Allen G Oliver; Lowell D Markley; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2014-05-28       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.